Cannabis Law Report

SEPTEMBER 24, 2019

T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. The medication, developed by GW Pharmaceuticals, will be used in combination with another epilepsy medication called clobazam. What about other medical cannabis products?

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

Veriheal

AUGUST 31, 2020

Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. Essay: “Can Cannabis Improve Patient Experience Post-Surgery?” . Vaibhav Duggal . School: Texas A&M University .

Research and Development 117

Research and Development Education Agriculture Patients 117

The Cannigma

JUNE 15, 2021

Some healthcare professionals are already encouraged by what is known, much of it anecdotal accounts from patients in their practices. The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. Shutterstock).

CBD 122

CBD Research and Development Epilepsy Extraction 122

CannaTech

AUGUST 9, 2018

We are delighted to introduce you to some new friends set to make a big impact on the medical cannabis advocacy scene… the creators of a new documentary called Separating the Strains ; a deeply personal narrative that charts the reality of living with epilepsy, with and without cannabis medication as a treatment option.

Strains 69

Strains Epilepsy Advocacy Medicine 69

Veriheal

DECEMBER 28, 2021

This is according to recent data from a report published by Market Research Future (MRT) – a pioneer in market analysis. It is because of the dedication of advocates and scientists that the medical cannabis industry is expected to generate a compound annual growth rate (CAGR) of 1 8.4% Amyotrophic lateral sclerosis (ALS). Alzheimer’s.

Research and Development 98

Research and Development Chronic Pain Treatment Medicine 98

Veriheal

MAY 31, 2022

According to data released by the Centers for Disease Control and Prevention , there were an estimated 2,620 opioid overdose deaths in Texas between Aug. A 2019 study found that 76% of patients in the U.S. fill an opioid prescription after having surgery compared to just 11% of Swedish patients.

Programs 52

Programs Chronic Pain Treatment Conditions 52

Freedom Leaf

OCTOBER 15, 2018

On the basis of their review, the agency approved Epidiolex for use in treating rare forms of childhood epilepsy (Lennox-Gastaut syndrome and Dravet syndrome). Frontier Data predicts total sales of all CBD products in the U.S. Frontier Data predicts total sales of all CBD products in the U.S. will top $1.9 billion by 2022.

DEA 51

DEA CBD Pharmaceutical Epilepsy 51

Leaf Science

JULY 23, 2019

In the UK, cannabis was legalized for medicinal purposes in 2018 which saw patients of epilepsy and multiple sclerosis able to access pharmaceutical cannabis derivatives such as Sativex and Epidiolex.

Strains 74

Strains Cannabinoids Epilepsy THC 74

Veriheal

OCTOBER 5, 2020

Hawaii legalized cannabis in its’ House Bill 2729 which was passed in 2018. The program requires cannabis patients to have a licensed physician to certify that the individual would benefit from medical cannabis before they can register for it. The caregiver must be over 18 years old and patients may only have one caregiver. .

Edibles 52

Edibles Legalization Decriminalization Consumption 52

CannaMD

SEPTEMBER 15, 2020

Current Florida medical marijuana patient? Patients suffering from cancer, epilepsy, chronic seizures, or muscle spasms could use low-THC cannabis products recommended by a licensed doctor. Doctors and patients had to register on the Compassionate Use Registry , an online database maintained by the Florida Department of Health.

Law 126

Law Marijuana Patients Treatment 126

Cannabis Law Report

AUGUST 5, 2019

When it comes to food or “health” products containing cannabidiol, commonly known as CBD, the federal government is not keeping up with the marketplace, where sales of CBD products topped $500 million in 2018. Read more. . Leafwire Closes $1M Funding Round. . ” Read more. . Read more. . Medical Marijuana, Inc.

Law 40

Law Decriminalization Hemp Legislation 40

Cannabis Law Report

MARCH 3, 2020

Hot coffee, friendly staff, and medical cannabis eagerly greet patients and guests on Feburary 15, 2020 at the Grand Opening of MÜV Dispensary on Ninth Avenue in Pensacola, Florida. . We strive to make a firsthand connection with every patient or caretaker to provide them with reliable and effective cannabis based therapies.

Dispensary 64

Dispensary Patients Cannabis Wellness and Beauty 64

Cannabis Law Report

SEPTEMBER 12, 2021

I certainly hope that other states follow Nevada’s lead and provide reassurances to licensed veterinarians that they can administer CBD or talk about it with patients without fear of facing disciplinary proceedings,” he said. But do medical cannabinoids actually help animal patients? Although products containing 0.3% A simple question.

Patients 105

Patients Pets Seed-To-Sale Cannabinoids 105

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. Silver Spring, MD: US Food and Drug Administration; June 25, 2018.

CBD 144

CBD Seed-To-Sale Food Access 144

CannaTech

SEPTEMBER 23, 2019

The acceptance of medical cannabis by clinicians, researchers and government bodies is fairly universal, and patients have benefited from widespread access to full-spectrum cannabis in flower and oil form. Israel’s approach to cannabis has contributed to reducing stigma and increasing access for patients around the world.

Patients 79

Patients Policy Clinical Trials Research and Development 79

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. At the same time, the outlook on cannabis research data is largely positive. 2018 ; Frankhauser 2008 ).

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

JULY 12, 2019

As reported in the Guardian, Analytical Cannabis emphasises the importance of this for those suffering from conditions such as chronic pain, epilepsy and neurological and psychiatric disorders who have long been seeking access to what they hope is a transformative medicine. Background to the legalisation of medical cannabis in the UK.

Epilepsy 40

Epilepsy Medicine Clinical Trials Chronic Pain 40

Cannabis Law Report

OCTOBER 26, 2019

The TGA does not evaluate any data relating to the trial. iv Named-patient and compassionate use proceduresThe TG Act provides mechanisms that allow individuals to gain limited access to UTGs (defined in Section II.iii). The institution at which the trial will be conducted gives the final approval.

Clinical Trials 45

Clinical Trials Medicine Research and Development Compliance 45

SMPL

MAY 26, 2020

Miller spent the months after this meeting leading hundreds of CBD seminars for farmers; Dr. Kerr began informal patient surveys to track how CBD made people feel; and as he finished his book, Mr. Lee often traveled around with Mr. Laughter and Mr. Ringo’s high-CBD plants and seeds, spreading the gospel at pot shops across the West.

CBD 40

CBD Research and Development Pharmaceutical Seed-To-Sale 40

Weedistry

MARCH 8, 2019

In 2018, medical cannabis became legal in the UK after a nationwide outpouring of support for two young boys who rely on cannabis oil to treat their severe and rare forms of epilepsy, but lingering concerns around the safety and efficiency of the medicine mean that access is still heavily restricted. THC – between 2015 and 2017.

Oil 40

Oil Treatment Patients THC 40

Green Relief

MAY 13, 2018

LEE ON MAY 02, 2018. A 2014 study found that traumatic brain injury ( TBI ) patients who tested positive for THC were more likely to survive with less impairment than TBI patients who abstained from marijuana. It is the most commonly identified cause of epilepsy among adults. But the U.S. BY MARTIN A. The patent.

THC 64

THC CBD Cannabinoids Research and Development 64

Green Relief

MAY 12, 2018

LEE ON MAY 02, 2018. A 2014 study found that traumatic brain injury ( TBI ) patients who tested positive for THC were more likely to survive with less impairment than TBI patients who abstained from marijuana. It is the most commonly identified cause of epilepsy among adults. But the U.S. BY MARTIN A. The patent.

Research and Development 40

Research and Development Cannabinoids Therapy CBD 40

Sensi Seeds

DECEMBER 10, 2018

They evaluate data, which is now available thanks to the efforts of the cannabis policy reform movement, and try to provide answers, especially to those who need them most, namely, medical patients. Consequently, they sorted the publications into three main groups: psychiatry, cancer treatment, and neurology.

Medicine 81

Medicine Research and Development Data Policy 81

Cannabis Law Report

JULY 12, 2019

Side effects were very prevalent in 79% of all patients taking a refined CBD product, some of which were severe like thrombocytopenia and transaminase elevations in the liver. Review: During an open-label trial of pure CBD with Lennox-Gastaut and Dravet patients, 79% of all patients reported side effects.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

Puff Puff Post

DECEMBER 28, 2018

An official study is aimed to conclude in July of 2019, where we’ll see all the data which comes forth. A sample of 120 patients aged between 5 and 29 years old with mild to severe autism are currently being given two different cannabis oil formulas or placebo. 80 % of parents noticed a reduction in negative behaviors.

Treatment 76

Treatment Oil CBD Therapy 76

StrainConnect

FEBRUARY 8, 2019

As of August 2018, researchers have found more than “144 known cannabinoids” This, according to leading scientist, Dedi Meiri, Ph.D.(10) From cancer(11) to epilepsy(12), there seems to be very little that cannabis cannot help with. 2018, April). The actual CBD is exactly the same no matter the source.

Hemp 57

Hemp CBD Cannabinoids Sativa 57

The Cannigma

SEPTEMBER 15, 2022

People with autism often have comorbid diagnoses such as anxiety, depression, sleep disturbances, ADHD, epilepsy, allergies, autoimmune conditions, and gastrointestinal conditions. A 2019 study of 188 ASD patients treated with 30% CBD oil with 1.5% The study found: self-injury and rage attacks improved in 67.6%

Terpenes 91

Terpenes Strains Sleep THC 91

Cannabis Law Report

SEPTEMBER 12, 2019

In December 2018, Jeff Smith predicted that Florida’s $250M medical cannabis market could open up to new businesses in 2019 : “Florida’s $250 million medical marijuana market is poised to swing its doors open to new companies next year after two judicial rulings in recent months that could reshape the competitive landscape.

Seed-To-Sale 65

Seed-To-Sale Supply Chain Business Programs 65

Cannabis Law Report

OCTOBER 17, 2019

Some of the potential health benefits associated with THC and CBD, with and without the high, respectively, include reducing chronic pain such as from migraines or cancer, alleviating anxiety, reducing inflammation, and helping treat conditions such as epilepsy, PTSD, and glaucoma. billion in 2025, according to Grandview Research.

Law 40

Law Seed-To-Sale Hemp Recreational 40

Cannabis Law Report

SEPTEMBER 19, 2019

Medicinal cannabis was technically legalised at the start of November 2018 following several high-profile cases about children with severe forms of epilepsy being unable to access potentially life-changing cannabis-based treatment. to explore how its transdermal system could be used to make cannabis-based products for patients.

Pharmaceutical 40

Pharmaceutical Research and Development Medicine Oil 40

NORML

AUGUST 26, 2019

Virginia has been one of the most reluctant states to consider marijuana law reform, though it recently began allowing some forms of cannabis oil for approved patients. Then, in 2017 and 2018, Virginia finally made some moves to establish its own medical marijuana industry. JM Pedini | Photo by Adam Ewing.

Marijuana 213

Marijuana Legalization Programs Oil 213